Palmoplantar Keratoderma
Symptoms, Doctors, Treatments, Advances & More

Palmoplantar Keratoderma Overview

Save information for later
Sign Up

Learn About Palmoplantar Keratoderma

What is the definition of Palmoplantar Keratoderma?
Palmoplantar keratoderma (PPK) is a group of skin conditions characterized by thickening of the skin on the palms of the hands and soles of the feet. PPK can also be a feature of various underlying syndromes. In rare forms of PPK, organs other than the skin may also be affected. PPK can be either acquired during the lifetime (more commonly) or inherited. Acquired PPKs may arise due to changes in a person's health or environment. Inherited PPKs are caused by genetic changes that result in abnormalities of keratin, a skin protein. Depending on the genetic cause, inheritance can be autosomal dominant or autosomal recessive.
What are the alternative names for Palmoplantar Keratoderma?
  • Palmoplantar keratoderma
  • Keratoderma, Palmoplantar
Who are the top Palmoplantar Keratoderma Local Doctors?
Elite in Palmoplantar Keratoderma
Elite in Palmoplantar Keratoderma
Referral may be required
Tsukuba, JP 

Toshifumi Nomura practices practicing medicine in Tsukuba, Japan. Nomura is rated as an Elite expert by MediFind in the treatment of Palmoplantar Keratoderma. They are also highly rated in 24 other conditions, according to our data. Their clinical expertise encompasses Palmoplantar Keratoderma, Acrokeratoelastoidosis of Costa, Nonbullous Congenital Ichthyosiform Erythroderma, and Epidermolytic Hyperkeratosis.

Elite in Palmoplantar Keratoderma
Elite in Palmoplantar Keratoderma
Referral may be required
Paris, FR 

Alain Hovnanian practices practicing medicine in Paris, France. Mr. Hovnanian is rated as an Elite expert by MediFind in the treatment of Palmoplantar Keratoderma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Netherton Syndrome, Olmsted Syndrome, Dystrophic Epidermolysis Bullosa, and Epidermolysis Bullosa.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Palmoplantar Keratoderma
Elite in Palmoplantar Keratoderma
Referral may be required
Sapporo, JP 

Toshinari Miyauchi practices practicing medicine in Sapporo, Japan. Miyauchi is rated as an Elite expert by MediFind in the treatment of Palmoplantar Keratoderma. They are also highly rated in 9 other conditions, according to our data. Their clinical expertise encompasses Acrokeratoelastoidosis of Costa, Palmoplantar Keratoderma, Epidermolytic Hyperkeratosis, and Nonbullous Congenital Ichthyosiform Erythroderma.

View All Doctors
What are the latest Palmoplantar Keratoderma Clinical Trials?
National Cohort for Evaluation of the Burden of Rare Skin Diseases
National Cohort for Evaluation of the Burden of Rare Skin Diseases
Enrollment Status: Recruiting
Publish Date: February 12, 2026

Summary: The goal of this observational study is to conduct a prospective assessment of the individual Burden of 9 rare skin diseases to assess disability in the broadest sense of the term (psychological, social, economic and physical) for patients and/or families. Two types of indicators will be used to reach this objective : 1. an individual burden score calculated based on a burden questionnaire created...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Investigating Perspectives of Patients With Genodermatosis and Healthcare Professionals on Reproductive Counselling
Investigating Perspectives of Patients With Genodermatosis and Healthcare Professionals on Reproductive Counselling
Enrollment Status: Recruiting
Publish Date: May 18, 2025
Intervention Type: Other

Summary: The goal of this observational study is to understand the perspectives and needs of patients with genodermatoses and their partners who wish to have children, regarding their decision-making process and their consideration of reproductive options. Additionally, the investigators aim to investigate the level of knowledge and perspectives of healthcare professionals (such as clinical geneticists, de...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center